The role of RAR and RXR activation in retinoid-induced tissue factor suppression

Leukemia

Volumn 14, Issue 6, 2000, Pages 1105-1111

  Tenno, T ^a   Botling, J ^a   Oberg F ^a   Jossan, S ^a   Nilsson, K ^a   Siegbahn, A ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Differentiation; RAR; RXR; Tissue factor

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1,3 DIOXOLAN 2 YL]BENZOIC ACID; RECEPTOR SUBUNIT; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; THROMBOPLASTIN;

ACUTE MYELOBLASTIC LEUKEMIA; AGONIST; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN U937; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING;

EID: 0034129710     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401785     Document Type: Article

References (40)

1. Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997; 78: 759-764.
2. Brozna JP. Cellular regulation of tissue factor. Blood Coagul Fibrinolysis 1990; 1: 415-426.
3. Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983; 49: 5-7.
4. Asakura H, Kamikubo Y, Goto A, Shiratori Y, Yamazaki M, lokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Aoshima K, Nakamura S, Matsuda T. Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995; 80: 217-224.
5. Andoh K, Kubota T, Takada M, Tanaka H, Kobayashi N, Maekawa T. Tissue factor activity in leukemia cells: special reference to disseminated intravascular coagulation. Cancer 1987; 59: 748-754.
6. Stephens AC, Zheng KQ, Russell AR, Levin M, Rivers RP. Production of tissue factor by monocyte progenitor cells. Thromb Res 1994; 76: 33-45.
7. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936-2940.
8. Olsson ILE, Breitman TR. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′:5′-monophosphate-inducing agents. Cancer Res 1982; 42: 3924-3927.
9. Koyama T, Hirosawa S, Kawamata N, Tohda S, Aoki N. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic: cells. Blood 1994; 84: 3001-3009.
10. Saito T, Koyama T, Nagata K, Kamiyama R, Hirosawa S. Anticoagulant effects of retinoic acids on leukemia cells. Blood 1996; 87: 657-665.
11. Tenno T, Öberg F, Nilsson K, Siegbahn A. Induction of differentiation in U-937 and NB4 cells is associated with inhibition of tissue factor production. Eur J Haematol 1999; 63: 112-119.
12. Barbui T, Finazzi G, Falanga A. The impact of all-trans retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 1998; 91: 3093-3102.
13. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83: 841-850.
14. Boiling J, Castro DS, Öberg F, Nilsson K, Perlmann T. Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation. J Biol Chem 1997; 272: 9443-9449.
15. Brooks SC, Kazmer S, Levin AA, Yen A. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Blood 1996; 87: 227-237.
16. Melnick A, Licht JD. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167-3215.
17. Shibakura M, Koyama T, Saito T, Shudo K, Miyasaka N, Kamiyama R, Hirosawa S. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells. Blood 1997; 90: 1545-1551.
18. Falanga A, Consonni R, Marchetti M, Locatelli G, Garattini E, Passerini CG, Gordon SG, Barbui T. Cancer procoagulant and tissue factor are differently modulated by all-twos retinoic acid in acute promyelocytic leukemia cells. Blood 1998; 92: 143-151.
19. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080-1086.
20. Sundström C, Nilsson K. Establishment and characterization of a human histocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565-577.
21. Åsjö B, Ihved I, Gidlund M, Fuerstenberg S, Fenyö EM, Nilsson K, Wigzell H. Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parential monocytoid cell line and its subclones. Virology 1987; 157: 359-365.
22. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-994.
23. Lindmark E, Tenno T, Chen J, Siegbahn A. IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood. Br J Haematol 1998; 102: 597-604.
24. Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI, Pfahl M. Retinoids selective tor retinoid X receptor response pathways. Science 1992; 258: 1944-1946.
25. Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988; 71: 870-875.
26. Bollag W, Isnardi L, Jablonska S, Klaus M, Majewski S, Pirson W, Toma S. Links between pharmacological properties of retinoids and nuclear retinoid receptors. Int J Cancer 1997; 70: 470-472.
27. Tenno T, Botling J, Öberg F, Nilsson K, Siegbahn A. Tissue factor expression in human monocytic cell lines. Thromb Res 1997; 88: 215-228.
28. James SY, Williams MA, Newland AC, Colston KW. Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol 1999; 32: 143-154.
29. Tallman MS, Hakimian D, Kwaan HC, Rickles FR. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia. Leuk Lymphoma 1993; 11: 27-36.
30. Shibakura M, Koyama T, Ohsawa M, Kamiyama R, Hirosawa S. A retinoic acid receptor-α (RARα) selective agonist modulates procoagulant activity of acute promyelocytic cells and induces their differentiation into neutrophils. Blood 1998; 91: 724-725.
31. Chen JY, Clifford J, Zusi C, Starrett J, Tortolani D, Ostrowski J, Reczek PR, Chambon P, Gronemeyer H. Two distinct actions of retinoid-receptor ligands. Nature 1996; 382: 819-822.
32. Brooks SC, Sturgill R, Choi J, Yen A. An RXR-selective analog attenuates the RARα-selective analog-induced differentiation and non-G1-restricted growth arrest of NB4 cells. Exp Cell Res 1997; 234: 259-269.
33. Botling J, Öberg F, Törmä H, Tuohimaa P, Bläuer M, Nilsson K. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells. Cell Growth Differ 1996; 7: 1239-1249.
34. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-954.
35. Hong SH, David C, Wong CW, Dejean A, Privalsky ML. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 9028-9033.
36. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T. Accelerated degradation of PML-retinoic acid receptor α (PML-RARα) oncoprotein by all-trans retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res 1996; 56: 2945-2948.
37. Benoit G, Altucci L, Flexor M, Ruchaud S, Lillehaug J, Raffelsberger W, Gronemeyer H, Lanotte M. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J 1999; 18: 7011-7018.
38. Apfel CM, Kamber M, Klaus M, Mohr P, Keidel S, LeMotte PK. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor. J Biol Chem 1995; 270: 30765-30772.
39. Boehm MF, McClurg MR, Pathirana C, Mangelsdorf D, White SK, Hebert J, Winn D, Goldman ME, Heyman RA. Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem 1994; 37: 408-414.
40. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W, Klaus M. A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 1992; 89: 7129-7133.